Persistent Skin Symptoms after Diagnosis and on a Long-term Gluten-free Diet in Dermatitis Herpetiformis.


Journal

Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310

Informations de publication

Date de publication:
22 Sep 2021
Historique:
pubmed: 8 9 2021
medline: 25 9 2021
entrez: 7 9 2021
Statut: epublish

Résumé

Dermatitis herpetiformis is a cutaneous manifestation of coeliac disease treated with a gluten-free diet. However, the itching and blistering rash alleviates slowly after gluten withdrawal and occasionally persists despite a long-term gluten-free diet. This study investigated the prevalence and factors associated with prolonged (i.e. >2 years) and ongoing skin symptoms in 237 patients with dermatitis herpetiformis. Data were gathered from medical records and via questionnaires. Among patients with dermatitis herpetiformis, 38% had prolonged symptoms after diagnosis, and 14% had ongoing skin symptoms at follow-up (median duration of gluten-free diet 24 years). A severe rash at diagnosis was associated with both prolonged and ongoing cutaneous symptoms. In addition, patients with dermatitis herpetiformis with ongoing skin symptoms at follow-up had been on the dietary treatment for a shorter time (median duration 16 vs 25 years) and were less often on a strict diet (53% vs 78%) compared with patients with dermatitis herpetiformis without ongoing skin symptoms.

Identifiants

pubmed: 34490466
doi: 10.2340/00015555-3914
pmc: PMC9425629
doi:

Substances chimiques

Glutens 8002-80-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

adv00555

Références

Clin Dev Immunol. 2012;2012:640630
pubmed: 22611420
Baillieres Clin Gastroenterol. 1995 Jun;9(2):231-49
pubmed: 7549026
J Invest Dermatol. 2014 Jun;134(6):1527-1534
pubmed: 24166134
Scand J Gastroenterol. 1998 Sep;33(9):933-8
pubmed: 9759948
Acta Derm Venereol. 1986;66(3):245-50
pubmed: 2426903
Int J Dermatol. 2018 Aug;57(8):959-964
pubmed: 29752728
Am J Clin Dermatol. 2015 Dec;16(6):545-52
pubmed: 26267424
Acta Derm Venereol. 2017 Jan 4;97(1):58-62
pubmed: 27241271
Lancet. 1973 Feb 10;1(7798):288-91
pubmed: 4119171
Br J Dermatol. 2011 Aug;165(2):354-9
pubmed: 21517799
Arch Dermatol. 1969 Aug;100(2):129-35
pubmed: 5797952
Dig Liver Dis. 2012 Oct;44(10):814-8
pubmed: 22673312
Acta Derm Venereol. 2020 Nov 12;100(18):adv00319
pubmed: 32985674
Dig Dis Sci. 1988 Feb;33(2):129-34
pubmed: 3123181
Acta Derm Venereol. 2018 Feb 7;98(2):195-199
pubmed: 29048096
Am J Clin Nutr. 2004 Apr;79(4):669-73
pubmed: 15051613
Nutrients. 2020 Apr 11;12(4):
pubmed: 32290504
Br J Dermatol. 2004 Jan;150(1):136-8
pubmed: 14746628
Acta Derm Venereol. 2020 Mar 12;100(6):adv00073
pubmed: 32016441
Br J Dermatol. 2003 Nov;149(5):968-71
pubmed: 14632800
Arch Dermatol. 1996 Aug;132(8):912-8
pubmed: 8712841
Nutrients. 2018 May 19;10(5):
pubmed: 29783727
Scand J Gastroenterol Suppl. 1996;221:8-13
pubmed: 9110389
Clin Exp Dermatol. 1994 May;19(3):210-6
pubmed: 8033378
Br J Dermatol. 2012 Dec;167(6):1331-7
pubmed: 22708883
BMC Gastroenterol. 2013 Apr 30;13:75
pubmed: 23631482
Br J Dermatol. 1982 Dec;107(6):631-40
pubmed: 7171483
Nutrients. 2018 Mar 14;10(3):
pubmed: 29538319
Eur J Dermatol. 2017 Aug 1;27(4):353-358
pubmed: 28524056
Clin Gastroenterol Hepatol. 2011 Feb;9(2):118-23
pubmed: 21029791
Acta Derm Venereol. 2015 Nov;95(8):917-22
pubmed: 26059085
Acta Derm Venereol. 2020 Feb 12;100(5):adv00056
pubmed: 32039457
Br Med J. 1969 Dec 27;4(5686):772-5
pubmed: 5359941
Dig Liver Dis. 2006 Jun;38(6):374-80
pubmed: 16627018
N Engl J Med. 2003 Jun 19;348(25):2517-24
pubmed: 12815137
Curr Gastroenterol Rep. 2020 Mar 17;22(4):18
pubmed: 32185560
J Invest Dermatol. 2019 Oct;139(10):2108-2114
pubmed: 30998982
Br J Dermatol. 1994 Oct;131(4):541-5
pubmed: 7947207
Acta Derm Venereol. 2016 Jan;96(1):82-6
pubmed: 26084552
Dig Liver Dis. 2006 Mar;38(3):177-80
pubmed: 16461026
Br J Dermatol. 2015 Apr;172(4):1139-41
pubmed: 25196300
Br J Dermatol. 1977 Nov;97(5):473-80
pubmed: 588461

Auteurs

Camilla Pasternack (C)

Celiac Disease Research Center, Faculty of Medicine and Health Technology, Tampere University, FIN-33014 Tampere, Finland. E-maill: camilla.pasternack@tuni.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH